Literature DB >> 7865966

The distribution of secretory immunoglobulin A in the intrahepatic biliary epithelium of patients with hepatolithiasis.

H Hamba1, H Kinoshita, K Hirohashi, S Kubo, N Fujio.   

Abstract

In the treatment of hepatolithiasis, liver resection helps to prevent recurrence and may reduce the incidence of infection by removal of the atrophic tissue. This study was conducted to determine if the affected liver tissue in hepatolithiasis is inflamed or has lowered local immunity by examining the distribution of secretory immunoglobulin A (sIgA) and proliferating cell nuclear antigen (PCNA) in the intrahepatic biliary tracts of 27 patients with hepatolithiasis. Operative specimens were sectioned and stained with avidinbiotin complex, and the labeling index for both sIgA and PCNA was calculated as a percentage of the biliary epithelial cells stained. Cells stained for sIgA increased to a certain point as the cholangitis became more severe; however, in advanced cholangitis, with severe parenchymal atrophy or actively proliferating biliary epithelium, there were fewer cells stained for sIgA than in mild cholangitis. In hepatolithiasis, the decreased local immunity related to sIgA accompanied severe chronic proliferative cholangitis and parenchymal atrophy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7865966     DOI: 10.1007/bf01636321

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  9 in total

1.  [Intrahepatic IgA and secretory component distribution and the mechanism of hyperSigAnemia].

Authors:  M J Teng
Journal:  Zhonghua Wai Ke Za Zhi       Date:  1990-07

2.  Rat bile as a convenient source of secretory IgA and free secretory component.

Authors:  I Lemaître-Coelho; G D Jackson; J P Vaerman
Journal:  Eur J Immunol       Date:  1977-08       Impact factor: 5.532

3.  Receptor-mediated binding and uptake of immunoglobulin A by human liver.

Authors:  M Tomana; R Kulhavy; J Mestecky
Journal:  Gastroenterology       Date:  1988-03       Impact factor: 22.682

4.  Secretory component and immunoglobulins in the intrahepatic biliary tree and peribiliary gland in normal livers and hepatolithiasis.

Authors:  H Sugiura; Y Nakanuma
Journal:  Gastroenterol Jpn       Date:  1989-06

5.  Human secretory immunoglobulins. I. Salivary secretions from individuals with normal or low levels of serum immunoglobulins.

Authors:  P Brandtzaeg; I Fjellanger; S T Gjeruldsen
Journal:  Scand J Haematol Suppl       Date:  1970

Review 6.  Secretory immunoglobulins.

Authors:  T B Tomasi; J Bienenstock
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

7.  The role of intrahepatic portal venous stenosis in the formation and progression of hepatolithiasis: morphological evaluation of autopsy and surgical series.

Authors:  T Terada; Y Nakanuma; K Ueda
Journal:  J Clin Gastroenterol       Date:  1991-12       Impact factor: 3.062

8.  Pathologic features of hepatolithiasis in Japan.

Authors:  Y Nakanuma; K Yamaguchi; G Ohta; T Terada
Journal:  Hum Pathol       Date:  1988-10       Impact factor: 3.466

9.  IGA in human bile and liver.

Authors:  H Nagura; P D Smith; P K Nakane; W R Brown
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

  9 in total
  1 in total

Review 1.  Significance of controlling chronic proliferative cholangitis in the treatment of hepatolithiasis.

Authors:  Fu Yu Li; Nan Sheng Cheng; Hui Mao; Li Sheng Jiang; Jing Qiu Cheng; Quan Sheng Li; Sanjay Munireddy
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.